Related references
Note: Only part of the references are listed.OnabotulinumtoxinA Wear-off Phenomenon in the Treatment of Chronic Migraine
Alina Masters-Israilov et al.
HEADACHE (2019)
Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults
Cristina Tassorelli et al.
CEPHALALGIA (2018)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal
A. P. Andreou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
Lars Bendtsen et al.
JOURNAL OF HEADACHE AND PAIN (2018)
OnabotulinumtoxinA: An Effective Tool in the Therapeutic Arsenal for Chronic Migraine With Medication Overuse
Edoardo Caronna et al.
FRONTIERS IN NEUROLOGY (2018)
Persistence and switching patterns of oral migraine prophylactic medications among patients with chronic migraine: A retrospective claims analysis
Zsolt Hepp et al.
CEPHALALGIA (2017)
The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis
Manjit Matharu et al.
JOURNAL OF HEADACHE AND PAIN (2017)
Update on the Pharmacological Treatment of Chronic Migraine
Christina Sun-Edelstein et al.
CURRENT PAIN AND HEADACHE REPORTS (2016)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Theo Vos et al.
LANCET (2016)
The International Classification of Headache Disorders, 3rd edition (beta version)
Andre Bes et al.
CEPHALALGIA (2013)
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK
Anthony J. Batty et al.
JOURNAL OF MEDICAL ECONOMICS (2013)
The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: A Summary and Comparison With Other Recent Clinical Practice Guidelines
Elizabeth Loder et al.
HEADACHE (2012)
Chronic Migraine: Epidemiology and Disease Burden
Aubrey N. Manack et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
H. C. Diener et al.
CEPHALALGIA (2010)
Clinical Utility of an Instrument Assessing Migraine Disability: The Migraine Disability Assessment (MIDAS) Questionnaire
R.B. Lipton et al.
HEADACHE (2010)
HIT-6 and MIDAS as Measures of Headache Disability in a Headache Referral Population
Khara M. Sauro et al.
HEADACHE (2010)
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
David W. Dodick et al.
HEADACHE (2010)
EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force
S. Evers et al.
EUROPEAN JOURNAL OF NEUROLOGY (2009)
MIDAS and HIT-6 French translation: reliability and correlation between tests
E. Magnoux et al.
CEPHALALGIA (2008)
Patients' preference for migraine preventive therapy
Mario Fernando Prieto Peres et al.
HEADACHE (2007)
Migraine frequency and intensity: Relationship with disability and psychological factors
JE Magnusson et al.
HEADACHE (2003)
A six-item short-form survey for measuring headache impact: The HIT-6 (TM)
M Kosinski et al.
QUALITY OF LIFE RESEARCH (2003)
Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
WF Stewart et al.
NEUROLOGY (2001)
Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice
J Edmeads et al.
NEUROLOGY (2001)
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
WF Stewart et al.
PAIN (2000)
Share Paper
